Partners Grp E Regulatory News (PEY)

27 May 2008 16:50



News Release

Guernsey, 27 May 2008

Princess partnership Graphite Capital sells Summit Medical at 3x multiple

The Princess Private Equity Holding Limited ("Princess") partnership Graphite Capital has sold Gloucestershire-based medical firm Summit Medical Ltd., generating a return of more than three times the cost of its original investment. Graphite led a GBP 17 million management buy-in/buy-out in 2001, after which Summit has developed strongly in the UK and overseas, both organically and through strategic acquisitions. Profit and turnover have both more than doubled. Summit designs, produces and distributes world class medical devices and accessories primarily in the orthopaedic sector. Its customers include individual patients and medical practitioners as well as private and public health services in the UK and in over 30 export markets, including the USA and continental Europe.

Sandra Pajarola, Head of Partnership Investment at Princess's investment advisor Partners Group, comments: "The sale of Summit at a multiple of over 3x underlines the quality of our private equity investments. Demonstrating once again our ability to select partnerships which follow a value through growth strategy, turnover as well as the number of staff more than doubled and major new products were launched during the holding period. This transaction further substantiates that highly successful exits are achievable, irrespective of the current market environment."

About Princess

Princess is an investment holding company founded in 1999 and domiciled in Guernsey that invests in private equity and private debt investments. The Company is advised in its investment activities by Partners Group AG, a global alternative asset management firm listed on the SWX Swiss Exchange (ticker symbol: PGHN) with over CHF 24 billion assets under management in private equity, private debt, private real estate, listed alternative strategies, hedge funds and alternative beta strategies. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Frankfurt Stock Exchange (ticker symbol: PEY1) and on the London Stock Exchange (ticker symbol: PEY). Further information: www.princess-privateequity.net

Contacts

Princess Private Equity Holding Limited:

Ken Ball

General Manager

Phone: +44 1481 730 946

princess@princess-privateequity.net

www.princess-privateequity.net

Media enquiries:

Partners Group AG

Tamara Krebs

Communications 

Tel.: +41 41 768 85 26

tamara.krebs@partnersgroup.net

www.partnersgroup.net

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess Private Equity Holding Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan. 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document.

Approved by Partners Group (UK) Ltd., authorised and regulated by the Financial Services Authority in the United Kingdom.